Mental Disorders

274 trials 116 recruiting

Filter these 274 trials by phase, country and sponsor.

Open in Search →

Study to assess the efficacy and safety of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519420-25-00 Major Depressive Disorder 5 2025-10-22
Treatment of anaemia after caesarean with intravenous versus oral iron and postpartum depression: a multicentric randomized open-labelled co… Recruiting

2023-503283-17-00 Women who delivered by caesarean and have a moderate po 6 2025-10-22
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder Recruiting

2024-520333-68-00 Major Depressive Disorder 5 2025-09-26
Study to assess the efficacy and safety of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519418-29-00 Major Depressive Disorder 5 2025-09-19
Study to assess the efficacy and safety of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519421-37-00 Major Depressive Disorder 5 2025-08-28
CO2 challenge study of NTX-1955 in healthy participants Recruiting

2025-522281-68-00 Generalized Anxiety Disorder (GAD) 3 2025-08-08
A study to test how BI 3031185 is tolerated by people with borderline personality disorder or attention-deficit/hyperactivity disorder. Recruiting

2024-514296-17-00 Attention deficit hyperactivity disorder 3 2025-08-05
A study to assess the efficacy and safety of ITI-1284 as monotherapy treatment in patients with Generalized Anxiety Disorder Recruiting

2024-516684-82-00 Generalized Anxiety Disorder 4 2025-07-21
A double-blind, randomized, controlled trial on the effect of PEX010 for prolonged grief disorder Recruiting

2024-518218-24-00 Prolonged grief disorder 4 2025-07-17
Evaluation of p-glycoprotein alterations in treatment-resistant depression: a [18F]MC225 PET study Recruiting

2023-508303-20-01 depression 4 2025-07-14
A study to assess the efficacy and safety of ITI-1284 in the treatment of Psychosis Associated with Alzheimer's Disease Recruiting

2024-513035-25-00 Psychosis associated with Alzheimer’s Disease 4 2025-07-11
The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational … Recruiting

2024-512559-20-01 Major Depressive Disorder (MDD) 5 2025-07-10
Treatment with acetylcholine esterase inhibitors in anorexia nervosa : a multicenter double-blind randomised controlled trial versus placebo Recruiting

2024-511681-37-00 Anorexia nervosa 4 2025-07-02
Exploring GLP-1 Receptor Agonist Treatment for Adolescents with Antipsychotic-Related Obesity: The GOAL Study Recruiting

2024-517471-21-02 Adipositas 6 2025-06-24
A trial to investigate the effects of Cannabidiol plus Naltrexone on alcohol craving in patients with alcohol dependence Recruiting

2024-518164-12-00 Alcohol dependence 4 2025-06-16
Pharmacological treatment of compulsive sexual behaviour disorder Recruiting

2024-514490-22-01 Compulsive Sexual Behaviour Disorder 5 2025-06-12
A New Intervention for Implementation of Pharmacogenetics in Psychiatry Recruiting

2023-509680-25-00 Mood disorder (major depressive disorder and bipolar di 6 2025-06-03
PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients Recruiting

2023-510488-36-01 Chronic obstructive pulmonary disease (COPD), amyotroph 4 2025-06-01
Randomized, placebo-controlled clinical trial to investigate the safety and efficacy of two dexamfetamine sulfate formulations in adults wit… Recruiting

2024-515395-12-00 Adults with ADHD and moderate to severe depression 4 2025-05-22
High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study Recruiting

2023-508229-28-00 posttraumatic stress disorder 4 2025-05-16
Sema.Mood Recruiting

2024-511734-13-04 Unipolar depression Overweight and obesity 11 2025-05-15
Traitement des Idées Suicidaires aux urgences par adjonction de Protoxyde d’Azote (PROTORISC pilote) Recruiting

2023-506329-12-00 Treatment of suicidal ideation 4 2025-05-14
Can treatment with tirzepatide reduce alcohol intake in individuals diagnosed with schizophrenia and alcohol use disorder (DUALPSYCHIATRY) Recruiting

2024-518608-28-00 Schizophrenia and Alcohol Use Disorder 4 2025-05-01
A Phase 3, Parallel Group Study to Evaluate KarXT as a Treatment for Psychosis Associated with Alzheimer’s Disease Recruiting

2024-516363-92-00 Psychosis Associated with Alzheimer’s Disease 5 2025-04-08